Literature DB >> 26328803

"To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists".

Francesco Dentali1, Nicola Mumoli2, Monica Gianni3, Marco Cei2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26328803     DOI： 10.1007/s11739-015-1313-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  21 in total

1.  Risk of bleeding with dabigatran in atrial fibrillation.

Authors:  Inmaculada Hernandez; Seo Hyon Baik; Antonio Piñera; Yuting Zhang
Journal:  JAMA Intern Med       Date:  2015-01       Impact factor: 21.873

2.  Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.

Authors:  Benjamin A Steinberg; Melissa A Greiner; Bradley G Hammill; Lesley H Curtis; Emelia J Benjamin; Susan R Heckbert; Jonathan P Piccini
Journal:  Cardiovasc Ther       Date:  2015-08       Impact factor: 3.023

3.  Risks of oral anticoagulant therapy with increasing age.

Authors:  Marieke Torn; Ward L E M Bollen; Felix J M van der Meer; Ernst E van der Wall; Frits R Rosendaal
Journal:  Arch Intern Med       Date:  2005-07-11

Review 4.  Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.

Authors:  Ricarda Marinigh; Gregory Y H Lip; Nicola Fiotti; Carlo Giansante; Deirdre A Lane
Journal:  J Am Coll Cardiol       Date:  2010-09-07       Impact factor: 24.094

Review 5.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

6.  Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? No.

Authors:  Marco Marietta
Journal:  Intern Emerg Med       Date:  2015-07-14       Impact factor: 3.397

7.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

8.  Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Authors:  Stuart J Connolly; Janice Pogue; John Eikelboom; Gregory Flaker; Patrick Commerford; Maria Grazia Franzosi; Jeffrey S Healey; Salim Yusuf
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

9.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13

10.  Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy.

Authors:  D Ferro; L Loffredo; L Polimeni; F Violi
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.